82 related articles for article (PubMed ID: 952206)
1. [Drug therapy of ovarian tumors].
Pérez Manga G; Madrigal Alonso L; Beca Figuier JM; Ureña Castro G
Acta Oncol (Madr); 1976; 11(1):27-32. PubMed ID: 952206
[No Abstract] [Full Text] [Related]
2. Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.
Hakes TB; Daghestani AN; Dougherty JB; Weiselberg L; Raymond V
Cancer Treat Rep; 1985 May; 69(5):559-60. PubMed ID: 3859369
[No Abstract] [Full Text] [Related]
3. [1st experiences in the treatment of ovarian tumors with Peptichemio].
Natale N; Mangioni C; Remotti G
Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
[No Abstract] [Full Text] [Related]
4. PCNU in advanced adenocarcinoma of the ovary: a phase II study.
Decker DA; Samson MJ; Baker LH
Cancer Treat Rep; 1983 May; 67(5):511-2. PubMed ID: 6850668
[No Abstract] [Full Text] [Related]
5. [Use of ftorafur for the treatment of 3d-4th stage].
Plaude RK; Osman VI; Tabachnik BI; Purinia IZh; Gutman EKh
Vopr Onkol; 1975; 21(3):44-7. PubMed ID: 1093324
[TBL] [Abstract][Full Text] [Related]
6. [Determination of individual sensitivity of malignant ovarian neoplasms to antineoplastic drugs].
Kulik GI; Abragam KA
Pediatr Akus Ginekol; 1969; 5():59-61. PubMed ID: 4994616
[No Abstract] [Full Text] [Related]
7. Phase II study of AMSA in patients with advanced ovarian cancer.
Kearsley JH; Coates AS; Fox RM; Tattersall MH; Page J; Levi JA
Cancer Treat Rep; 1982 May; 66(5):1242-3. PubMed ID: 6896295
[No Abstract] [Full Text] [Related]
8. [Therapeutic results of advanced malignant ovarian tumours].
Taubert W; Prager W
Radiobiol Radiother (Berl); 1973; 14(1):11-6. PubMed ID: 4689204
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
Brenner DE; Jones HW; Rosenshein NB; Forastiere A; Dillon M; Grumbine F; Tipping S; Burnett L; Greco FA; Wiernik PH
Cancer Treat Rep; 1983 Feb; 67(2):193-4. PubMed ID: 6825131
[No Abstract] [Full Text] [Related]
10. [Clinical use of prospidine].
Barsel' VA; Disvetova VV; Evseenko LS; Orlova RS; Tverdynin MS
Vopr Onkol; 1970; 16(8):36-41. PubMed ID: 5501882
[No Abstract] [Full Text] [Related]
11. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
Piver MS; Lele S; Barlow JJ
Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
[TBL] [Abstract][Full Text] [Related]
12. [Polyamines in the evaluation of the effectiveness of cancer patient treatment].
Bassalyk LS; Nemtsova MP; Merabishvili NV; Tevzadze TA; Korbukh IA
Vestn Akad Med Nauk SSSR; 1982; (3):57-61. PubMed ID: 6283759
[No Abstract] [Full Text] [Related]
13. [Cytostatic therapy of ovarian neoplasms].
Mattsson W
Lakartidningen; 1977 Sep; 74(39):3339-42. PubMed ID: 909354
[No Abstract] [Full Text] [Related]
14. Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.
George MJ; Heron JF; Kerbrat P; Chauvergne J; Goupil A; Lebrun D; Guastalla JP; Namer M; Bugat R; Ayme Y
Semin Oncol; 1989 Apr; 16(2 Suppl 4):30-2. PubMed ID: 2652318
[No Abstract] [Full Text] [Related]
15. Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Sutton GP; Homesley HD; Park R
Cancer Treat Rep; 1986 Feb; 70(2):309-10. PubMed ID: 3948196
[No Abstract] [Full Text] [Related]
16. High-dose medroxyprogesterone acetate (MPA) in advanced chemotherapy-resistant ovarian carcinoma: a phase II study.
Aabo K; Pedersen AG; Haid I; Dombernowsky P
Cancer Treat Rep; 1982 Feb; 66(2):407-8. PubMed ID: 6459846
[No Abstract] [Full Text] [Related]
17. Survival of patients with advanced ovarian carcinoma treated with Penberol.
Novotná J; Andrysek O; Kobilková J; Laurová L
Neoplasma; 1983; 30(2):245-50. PubMed ID: 6302531
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer: current management.
Tyler H; Kardinal CG
Mo Med; 1981 Jan; 78(1):13-6. PubMed ID: 7219403
[No Abstract] [Full Text] [Related]
19. [Chemotherapy for ovarian cancer].
Lindell A
Lakartidningen; 1968 Mar; 65(11):1120-2. PubMed ID: 5743130
[No Abstract] [Full Text] [Related]
20. [Chemotherapy of stage III and IV ovarian carcinoma].
Neijt JP; Barents JW; Vendrik CP; van Lindert AC; Struyvenberg A; Pinedo HM
Ned Tijdschr Geneeskd; 1980 Sep; 124(38):1601-5. PubMed ID: 7412949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
